Discover 165 paid clinical trials in Tulsa, Oklahoma. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 165
Protocol for Collecting, Banking and Distributing Human Tissue Samples: St. Jude Children's Research Hospital Tissue Resources Core Facility
for
Normal and Diseased Tissue and Body Fluids Samples
Location: Tulsa OK, Springfield MO, Fort Worth TX, Shreveport LA,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 0+
Code: NCT01354002
Recruiting
Adding Dasatinib Or Venetoclax To Improve Responses In Children With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia (ALL) Or Lymphoma (T-LLY) Or Mixed Phenotype Acute Leukemia (MPAL)
Location: Tulsa OK, Memphis TN, Baton Rouge LA, Charlotte NC,
Sponsor: St. Jude Children's Research Hospital
Sex: All
Age: 1 - 18
Code: NCT06289673
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)
for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Tulsa OK, Oklahoma City OK, Kansas City MO, Dallas TX,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 1 - 30
Code: NCT04546399
Phase2, Recruiting
Inotuzumab Ozogamicin and Post-Induction Chemotherapy in Treating Patients With High-Risk B-ALL, Mixed Phenotype Acute Leukemia, and B-LLy
for
B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma,
Location: Tulsa OK, Oklahoma City OK, Wichita KS, Kansas City MO,
Sponsor: Children's Oncology Group
Sex: All
Age: 1 - 25
Code: NCT03959085
Phase3, Recruiting
Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors
for
Childhood Extracranial Germ Cell Tumor,
Location: Tulsa OK, Oklahoma City OK, Wichita KS, Lawton OK,
Sponsor: Children's Oncology Group
Sex: All
Age: 0+
Code: NCT03067181
Phase3, Recruiting
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and Nivolumab